Form ARS NRX Pharmaceuticals, For: Dec 31
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Osmind study finds IV ketamine more effective than nasal esketamine for depression
- Senior Care Authority Releases Father's Day Guide with 10 Warning Signs that Aging Parents Need Support
- CVS Health To Deliver Faster, More Personalized Call Center Care for Millions of Members With Salesforce's Agentforce Health
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
